Repurposing the Public BraTS Dataset for Postoperative Brain Tumour Treatment Response Monitoring.

BraTS Brain Tumor Segmentation Challenge MRI annotation protocol automatic brain tumour segmentation deep learning algorithm magnetic resonance imaging postoperative treatment monitoring

Journal

Tomography (Ann Arbor, Mich.)
ISSN: 2379-139X
Titre abrégé: Tomography
Pays: Switzerland
ID NLM: 101671170

Informations de publication

Date de publication:
01 Sep 2024
Historique:
received: 10 06 2024
revised: 22 08 2024
accepted: 26 08 2024
medline: 27 9 2024
pubmed: 27 9 2024
entrez: 27 9 2024
Statut: epublish

Résumé

The Brain Tumor Segmentation (BraTS) Challenge has been a main driver of the development of deep learning (DL) algorithms and provides by far the largest publicly available expert-annotated brain tumour dataset but contains solely preoperative examinations. The aim of our study was to facilitate the use of the BraTS dataset for training DL brain tumour segmentation algorithms for a postoperative setting. To this end, we introduced an automatic conversion of the three-label BraTS annotation protocol to a two-label annotation protocol suitable for postoperative brain tumour segmentation. To assess the viability of the label conversion, we trained a DL algorithm using both the three-label and the two-label annotation protocols. We assessed the models pre- and postoperatively and compared the performance with a state-of-the-art DL method. The DL algorithm trained using the BraTS three-label annotation misclassified parts of 10 out of 41 fluid-filled resection cavities in 72 postoperative glioblastoma MRIs, whereas the two-label model showed no such inaccuracies. The tumour segmentation performance of the two-label model both pre- and postoperatively was comparable to that of a state-of-the-art algorithm for tumour volumes larger than 1 cm

Identifiants

pubmed: 39330751
pii: tomography10090105
doi: 10.3390/tomography10090105
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1397-1410

Subventions

Organisme : Danish Cancer Society
ID : R295-A16770

Auteurs

Peter Jagd Sørensen (PJ)

Department of Radiology, Centre of Diagnostic Investigation, Copenhagen University Hospital-Rigshospitalet, 2100 Copenhagen, Denmark.
Department of Clinical Medicine, University of Copenhagen, 2100 Copenhagen, Denmark.
The DCCC Brain Tumor Center, 2100 Copenhagen, Denmark.

Claes Nøhr Ladefoged (CN)

Department of Clinical Physiology and Nuclear Medicine, Centre of Diagnostic Investigation, Copenhagen University Hospital-Rigshospitalet, 2100 Copenhagen, Denmark.
Department of Applied Mathematics and Computer Science, Technical University of Denmark, 2800 Lyngby, Denmark.

Vibeke Andrée Larsen (VA)

Department of Radiology, Centre of Diagnostic Investigation, Copenhagen University Hospital-Rigshospitalet, 2100 Copenhagen, Denmark.

Flemming Littrup Andersen (FL)

Department of Clinical Medicine, University of Copenhagen, 2100 Copenhagen, Denmark.
Department of Clinical Physiology and Nuclear Medicine, Centre of Diagnostic Investigation, Copenhagen University Hospital-Rigshospitalet, 2100 Copenhagen, Denmark.

Michael Bachmann Nielsen (MB)

Department of Radiology, Centre of Diagnostic Investigation, Copenhagen University Hospital-Rigshospitalet, 2100 Copenhagen, Denmark.
Department of Clinical Medicine, University of Copenhagen, 2100 Copenhagen, Denmark.

Hans Skovgaard Poulsen (HS)

The DCCC Brain Tumor Center, 2100 Copenhagen, Denmark.

Jonathan Frederik Carlsen (JF)

Department of Radiology, Centre of Diagnostic Investigation, Copenhagen University Hospital-Rigshospitalet, 2100 Copenhagen, Denmark.
Department of Clinical Medicine, University of Copenhagen, 2100 Copenhagen, Denmark.

Adam Espe Hansen (AE)

Department of Radiology, Centre of Diagnostic Investigation, Copenhagen University Hospital-Rigshospitalet, 2100 Copenhagen, Denmark.
Department of Clinical Medicine, University of Copenhagen, 2100 Copenhagen, Denmark.
The DCCC Brain Tumor Center, 2100 Copenhagen, Denmark.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH